Biblio Discovery — Demo Discovery Service

3 hasil untuk "Palmer M. Netongo"

Menampilkan 1–3 · 1,61 detik · RSS

  1. Artikel Jurnal

    Comparison of the Accuracy of Four Malaria Diagnostic Methods in a High Transmission Setting in Coastal Cameroon

    Marcel N. Moyeh; Innocent M. Ali; Dieudonné L. Njimoh dkk.

    Journal of Parasitology Research, Vol. 2019 · 2019 · Inggris · DOAJ Scopus

    Background. Despite recommendation from the World Health Organization that all malaria suspected patients undergo a parasitological confirmation using rapid diagnostic test or light microscopy prior to treatment, health facilities in remote malaria endemic settings sometimes resort to presumptive…

  2. Artikel Jurnal

    Impaired clinical, biological, and cytokine patterns in HIV-1 exposed uninfected newborns in Yaoundé: A comparative study of neonatal immune vulnerability

    Sabine A. Touangnou-Chamda; Palmer M. Netongo; Jacky Njiki Bikoï dkk.

    African Journal of Laboratory Medicine, Vol. 15 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background: Immune dysregulation is hypothesised to underpin the heightened susceptibility of HIV-1-exposed uninfected (HEU) infants to morbidity and mortality, which occurs at a rate three times higher than that of HIV-1-unexposed uninfected (HUU) controls. However, robust evidence substantiating…

  3. Artikel Jurnal

    Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]

    Palmer M. Netongo; Akindeh M. Nji; Peter Thelma N. Niba dkk.

    Wellcome Open Research, Vol. 9 · 2024 · Inggris · DOAJ Scopus

    Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months from 2016, raising concerns whether drug…